Picture of SynAct Pharma AB logo

SYNACT — SynAct Pharma AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m+11.83%
3m
6m
1yr
Volume Change (%)
10d/3m
Price vs... (%)
52w High-4.28%
50d MA
200d MA

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for SYNACT

Will Synact Pharma Ab's price keep rising? background image

Will Synact Pharma Ab's price keep rising?

Studies by leading experts into the power of price momentum show that stocks with the strongest price trends can potentially keep up the pace for anywhere up to one year. A big part of the reason for this is down to investor psychology...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of SynAct Pharma AB EPS forecast chart

Profile Summary

SynAct Pharma AB is a manufacturer of biological products. The Company is located in Lund, Sweden. It develops medicines for acute impairment in inflammatory diseases. The company's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.

Directors

Last Annual
December 31st, 2020
Last Interim
September 30th, 2021
Incorporated
January 1st, 1970
Public Since
July 11th, 2016
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
se flag iconAktieTorget Stock Exchange
Shares in Issue
26,006,295
Blurred out image of a map
Address
Scheelevagen 2, LUND, 223 63
Web
https://www.synactpharma.com/
Phone
Contact
Jeppe Oevlesen
Auditors
Mazars SET Revisionsbyra AB

SYNACT Share Price Performance

Similar to SYNACT

Picture of Abera Bioscience AB logo

Abera Bioscience AB

se flag iconAktieTorget Stock Exchange

Picture of Aptahem AB logo

Aptahem AB

se flag iconAktieTorget Stock Exchange

Picture of Carbiotix AB (publ) logo

Carbiotix AB (publ)

se flag iconAktieTorget Stock Exchange

Picture of Cereno Scientific AB logo

Cereno Scientific AB

se flag iconAktieTorget Stock Exchange

Picture of Dextech Medical AB logo

Dextech Medical AB

se flag iconAktieTorget Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email